Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07227311
What this trial is testing

Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 200
Testing effectiveness (Phase 2)Study completedNCT02113319
What this trial is testing

Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
University Hospital, Angers 27
Testing effectiveness (Phase 2)Ended earlyNCT03547700
What this trial is testing

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Lymphoma, T-Cell, Peripheral
University of Michigan Rogel Cancer Center 11
Testing effectiveness (Phase 2)UnknownNCT03156101
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects

Who this might be right for
Relapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic LeukemiaRelapsed／Refractory B-cell Lymphoma
Shenzhen BinDeBio Ltd. 24
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Testing effectiveness (Phase 2)Looking for participantsNCT04047641
What this trial is testing

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaBlasts 20 Percent or More of Bone Marrow Nucleated CellsHigh Risk Myelodysplastic Syndrome+5 more
M.D. Anderson Cancer Center 80
Not applicableActive Not RecruitingNCT01492751
What this trial is testing

Effectiveness of Localized Prostate Cancer Treatments

Who this might be right for
Prostate Cancer
Fundacion IMIM 500
Early research (Phase 1)Study completedNCT04855929
What this trial is testing

A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.

Who this might be right for
Advanced Solid TumorAdult DiseaseLung Cancer
Anaveon AG 55
Testing effectiveness (Phase 2)Study completedNCT06083753
What this trial is testing

Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Janssen Research & Development, LLC 182
Large-scale testing (Phase 3)Looking for participantsNCT07071337
What this trial is testing

SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy

Who this might be right for
Metastatic Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430
Large-scale testing (Phase 3)Study completedNCT00758277
What this trial is testing

Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients

Who this might be right for
Alcohol DependenceAlcoholic Relapse
Charite University, Berlin, Germany 201
Testing effectiveness (Phase 2)Study completedNCT00218075
What this trial is testing

Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence

Who this might be right for
Cocaine AbuseCocaine-Related Disorders
The University of Texas Health Science Center, Houston 200
Not applicableUnknownNCT04776265
What this trial is testing

RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT

Who this might be right for
Hodgkin Lymphoma, AdultRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Grupo Argentino de Tratamiento de la Leucemia Aguda 100
Early research (Phase 1)Study completedNCT00012207
What this trial is testing

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Fred Hutchinson Cancer Center 12
Early research (Phase 1)Study completedNCT01221571
What this trial is testing

Assess AFM13 in Patients With Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Affimed GmbH 28
Not applicableWithdrawnNCT03138395
What this trial is testing

ICare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesAML+1 more
University of Florida
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT06822972
What this trial is testing

HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Duke University 27
Early research (Phase 1)Study completedNCT03236857
What this trial is testing

The Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

Who this might be right for
MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+2 more
AbbVie 143
Early research (Phase 1)Active Not RecruitingNCT04106219
What this trial is testing

LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Eli Lilly and Company 71
Next Page